Generics Makers Tell 3rd Circ. Buyers Too Few For Class
By P.J. D'Annunzio · June 2, 2026, 6:50 PM EDT
Two pharmaceutical companies embroiled in decadelong litigation over the alleged price-fixing of generic drugs told a Third Circuit panel on Tuesday that groups of drug buyers either didn't have the numbers...
To view the full article, register now.